Dr Slack is a clinical psychologist and the Project Manager for the HIV AIDS Vaccines Ethics Group (HAVEG) at the University of KwaZulu-Natal (http://www.saavi.org.za/haveg/index.htm). She is Principal Investigator or co-Principal Investigator of several grants awarded to HAVEG.
Her area is the ethics of clinical trials of HIV prevention modalities – including ‘community’/ stakeholder engagement, ancillary-care, informed consent, and adolescent enrolment. She is especially interested in how empirical data might best inform normative guidance https://www.researchgate.net/profile/Catherine_Slack
She has researched the ethical-legal framework for trials of HIV prevention products. She has developed resources to assist role-players apply ethical-legal norms. She has worked collaboratively with various stakeholders to address complexities, including investigators, RECs (IRBs) and community representatives.
Dr Slack was a member of the National Health Research Ethics Council in South Africa for 9 years (2007-2016). She was part of the WHO/UNAIDS Ethics, Law and Human Rights Collaborating Centre of the African AIDS Vaccine Program. She was part of the expert panel that helped draft the UNAIDS/WHO (2007) guidance document Ethical Considerations in Biomedical HIV Prevention Trials.
HAVEG is currently funded by the Canadian HIV Vaccine Initiative to explore the process aspects of consent communications; and by the United States Agency for International Development to strengthen ‘community’ engagement during ethics review.
Catherine Slack’s contact details are firstname.lastname@example.org